EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Fisher & Paykel Healthcare's Enterprise Value is A$19,606 Mil.
Fisher & Paykel Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was A$358 Mil. Therefore, Fisher & Paykel Healthcare's EV-to-FCF for today is 54.78.
The historical rank and industry rank for Fisher & Paykel Healthcare's EV-to-FCF or its related term are showing as below:
ASX:FPH'
s EV-to-FCF Range Over the Past 10 Years
Min: 31.54 Med: 71.44 Max: 599.89
Current: 55.4
During the past 13 years, the highest EV-to-FCF of Fisher & Paykel Healthcare was 599.89. The lowest was 31.54. And the median was 71.44.
ASX:FPH's EV-to-FCF is ranked worse than 71.39% of 374
companies
in the Medical Devices & Instruments industry
Industry Median: 28.735
vs ASX:FPH: 55.40
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Fisher & Paykel Healthcare's EV-to-FCF
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's EV-to-FCF falls into.
Fisher & Paykel Healthcare's current Enterprise Value is A$19,606 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was A$358 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fisher & Paykel Healthcare's PE Ratio (TTM) for today is calculated as:
Fisher & Paykel Healthcare's share price for today is A$33.36.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fisher & Paykel Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was A$0.278.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Fisher & Paykel Healthcare EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:FPH has been successfully added to your 